Table 1

Clinical and laboratory profiles of the 6 tested patients

PatientsLaboratory criteria
Clinical manifestations
LAaCLaβ2GP1 IgG
Patient 1 > 60 Thromboembolism 
Patient 2 > 60 Arterial thrombosis 
Patient 3 36 Recurrent fetal loss 
Patient 4 − – Venous thrombosis 
Patient 5 35 Venous thrombosis 
Patient 6 − > 60 Recurrent fetal loss 
PatientsLaboratory criteria
Clinical manifestations
LAaCLaβ2GP1 IgG
Patient 1 > 60 Thromboembolism 
Patient 2 > 60 Arterial thrombosis 
Patient 3 36 Recurrent fetal loss 
Patient 4 − – Venous thrombosis 
Patient 5 35 Venous thrombosis 
Patient 6 − > 60 Recurrent fetal loss 

LA indicates lupus anticoagulant; aCL IgG anticardiolipin antibodies (normal value < 5 IgG antiphospholipid [GPL] units); aβ2GP1 IgG, anti-β2glycoprotein 1 IgG; +, positive; −, negative.

Close Modal

or Create an Account

Close Modal
Close Modal